Gloviczki P, Lawrence PF, Wasan SM, Meissner MH, Almeida J, Brown KR, Bush RL, Di Iorio M, Fish J, Fukaya E, Gloviczki ML, Hingorani A, Jayaraj A, Kolluri R, Murad MH, Obi AT, Ozsvath KJ, Singh MJ, Vayuvegula S, Welch HJ, et al.
Journal of vascular surgery. Venous and lymphatic disorders. Date of publication 2024 Jan 1;volume 12(1):101670.
1. J Vasc Surg Venous Lymphat Disord. 2024 Jan;12(1):101670. doi:
10.1016/j.jvsv.2023.08.011. Epub 2023 Aug 29.
The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein
and Lymphatic Society clinical practice guidelines for the management of
varicose veins of the lower extremities. Part II: Endorsed by the Society of
Interventional Radiology and the Society for Vascular Medicine.
Gloviczki P(1), Lawrence PF(2), Wasan SM(3), Meissner MH(4), Almeida J(5), Brown
KR(6), Bush RL(7), Di Iorio M(8), Fish J(9), Fukaya E(10), Gloviczki ML(11),
Hingorani A(12), Jayaraj A(13), Kolluri R(14), Murad MH(15), Obi AT(16), Ozsvath
KJ(17), Singh MJ(18), Vayuvegula S(19), Welch HJ(20).
Author information:
(1)Division of Vascular and Endovascular Surgery, Gonda Vascular Center, Mayo
Clinic, Rochester, MN. Electronic address: gloviczki.peter@mayo.edu.
(2)Division of Vascular and Endovascular Surgery, Department of Surgery,
University of California, Los Angeles, CA.
(3)Department of Medicine, University of North Carolina, Chapel Hill, Rex
Vascular Specialists, UNC Health, Raleigh, NC.
(4)Division of Vascular Surgery, University of Washington, Seattle, WA.
(5)Division of Vascular and Endovascular Surgery, University of Miami Miller
School of Medicine, Miami, FL.
(6)Medical College of Wisconsin, Milwaukee, WI.
(7)John Sealy School of Medicine, University of Texas Medical Branch, Galveston,
TX.
(8)South Austin Vein Center, Austin, TX.
(9)Department of Medicine, Jobst Vascular Institute, University of Toledo,
Toledo, OH.
(10)Division of Vascular Surgery, Stanford University, Stanford, CA.
(11)Department of Internal Medicine and Gonda Vascular Center, Rochester, MN.
(12)NYU Brooklyn Medical Center, Brooklyn, NY.
(13)RANE Center for Venous and Lymphatic Diseases, Jackson, MS.
(14)Heart and Vascular Service, OhioHealth Riverside Methodist Hospital,
Columbus, OH.
(15)Evidence Based Practice Center, Robert D. and Patricia E. Kern Center for
the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
(16)University of Michigan, Ann Arbor, MI.
(17)Vascular Associates, St Peters Health Partners, Albany, NY.
(18)University of Pittsburgh Medical Center, Pittsburgh, PA.
(19)Vein Clinics of America, Plano, TX.
(20)Lahey Hospital and Medical Center, Burlington, MA.
The Society for Vascular Surgery, the American Venous Forum, and the American
Vein and Lymphatic Society recently published Part I of the 2022 clinical
practice guidelines on varicose veins. Recommendations were based on the latest
scientific evidence researched following an independent systematic review and
meta-analysis of five critical issues affecting the management of patients with
lower extremity varicose veins, using the patients, interventions, comparators,
and outcome system to answer critical questions. Part I discussed the role of
duplex ultrasound scanning in the evaluation of varicose veins and treatment of
superficial truncal reflux. Part II focuses on evidence supporting the
prevention and management of varicose vein patients with compression, on
treatment with drugs and nutritional supplements, on evaluation and treatment of
varicose tributaries, on superficial venous aneurysms, and on the management of
complications of varicose veins and their treatment. All guidelines were based
on systematic reviews, and they were graded according to the level of evidence
and the strength of recommendations, using the GRADE method. All ungraded
Consensus Statements were supported by an extensive literature review and the
unanimous agreement of an expert, multidisciplinary panel. Ungraded Good
Practice Statements are recommendations that are supported only by indirect
evidence. The topic, however, is usually noncontroversial and agreed upon by
most stakeholders. The Implementation Remarks contain technical information that
supports the implementation of specific recommendations. This comprehensive
document includes a list of all recommendations (Parts I-II), ungraded consensus
statements, implementation remarks, and best practice statements to aid
practitioners with appropriate, up-to-date management of patients with lower
extremity varicose veins.
Copyright © 2023. Published by Elsevier Inc.
DOI: 10.1016/j.jvsv.2023.08.011
PMID: 37652254 [Indexed for MEDLINE]
Conflict of interest statement: Disclosures J.F. is a paid speaker for Janssen
Pharmaceuticals. M.L.G. has been paid a consulting fee by VitasupportMD and is
on their advisory board. R.K. is a paid consultant for Abbott, Auxetics, Boston
Scientific, Diachii Sankyo, Koya Medical, Medtronic, Penumbra, Philips,
Surmodics, USA Therm, and VB Devices; is on DSMB/CEC for NAMSA and Prairie
Education and Research Cooperative; and is on the Board of Trustees of The VIVA
Foundation, the Society for Vascular Medicine, the American Vein and Lymphatic
Society, and the Intersocietal Accreditation Council | Vascular Testing. A.T.O.
is a primary investigator for preclinical research grants funded by Medtronic
and SurModics. K.O. is an IAC executive board member, serves on the advisory
board for Medtronic and Boston Scientific, is a speaker and ultrasound course
host for Medtronic, is a speaker for Boston Scientific, a quality committee
member of CDPHP, and PI for W. L. Gore & Associates, and for the Savve study for
enVVeno Medical. S.W. is a paid speaker for Janssen Pharmaceuticals. P.G.,
P.F.L., M.H.M., M.M., J.A., K.B., R.L.B., M.D., M.S. E.F., A.H., A.J., S.V., and
H.J.W. have no conflicts of interest.
